-+ 0.00%
-+ 0.00%
-+ 0.00%

ANGIODYNAMICS ANNOUNCES TWO-YEAR PRESERVE TRIAL DATA DEMONSTRATING DURABLE NANOKNIFE IRE SYSTEM OUTCOMES IN INTERMEDIATE-RISK PROSTATE CANCER

Reuters·05/13/2026 13:00:04

Please log in to view news